Healthfulness of Food From Grocery Stores Versus Eating Out Among People Receiving Food Benefits (SNAP) (SNAP)

December 7, 2017 updated by: University of North Carolina, Chapel Hill

Dietary Quality by At-home and Away-from-home Food Sources in the Supplemental Nutrition Assistance Program (SNAP)

The objective of this cross-sectional study was to characterize the dietary intake of SNAP participants and nonparticipants by food source, including grocery stores, sit-down restaurants, and fast food.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

The study used 4,237 low-income adults from the National Health and Nutrition Examination Survey (NHANES) (2003-2006 and 2011-2014). De-identified data was collected from demographic questionnaires and 24 hour dietary recalls. We assessed intake of calories, solid fats, added sugars, and servings of non-starchy vegetables, whole fruits, and whole grains, by food source in SNAP participants and income-eligible nonparticipants. Associations between SNAP participation and dietary intake were analyzed using multivariate linear regression controlling for relevant sociodemographic characteristics.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
4237

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

20 years to 64 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

4,237 low-income adults in the National Health and Nutrition Examination Survey (NHANES) (2003-2006 and 2011-2014)

Description

Inclusion Criteria:

  • Adults ages 20 - 64
  • At or below 200% of the federal poverty level
  • Completed at least one 24-hour dietary recall

Exclusion Criteria:

  • Younger than 20 years old or 65 years and older
  • Income above 200% the federal poverty level
  • No participation in dietary recall

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
2003-2004
Adults 20-64 at or below 130% of the federal poverty level who completed one 24-hour dietary recall
2005-2006
Adults 20-64 at or below 130% of the federal poverty level who completed one 24-hour dietary recall
2011-2012
Adults 20-64 at or below 130% of the federal poverty level who completed one 24-hour dietary recall
2013-2014
Adults 20-64 at or below 130% of the federal poverty level who completed one 24-hour dietary recall

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Caloric intake
Time Frame: 2003-2014
Number of calories consumed by SNAP participants compared to nonparticipants in 2003-2006 and 2011-2014 by source of food (including grocery stores, fast food restaurants, sit-down restaurants and other sources). SNAP participants will be compared to income-eligible nonparticipants at income levels up to 200% of the federal poverty level.
2003-2014
Solid fat
Time Frame: 2003-2014
Number of grams of solid fat and percent of intake from solid fat consumed by SNAP participants compared to nonparticipants in 2003-2006 and 2011-2014 by source of food (including grocery stores, fast food restaurants, sit-down restaurants and other sources). SNAP participants will be compared to income-eligible nonparticipants at income levels up to 200% of the federal poverty level.
2003-2014
Added sugar
Time Frame: 2003-2014
Number of grams of added sugar and percent of intake from added sugar consumed by SNAP participants compared to nonparticipants in 2003-2006 and 2011-2014 by source of food (including grocery stores, fast food restaurants, sit-down restaurants and other sources). SNAP participants will be compared to income-eligible nonparticipants at income levels up to 200% of the federal poverty level.
2003-2014
Non-starchy vegetables
Time Frame: 2003-2014
Cup-equivalent servings of non-starchy vegetables consumed by SNAP participants compared to nonparticipants in 2003-2006 and 2011-2014 by source of food (including grocery stores, fast food restaurants, sit-down restaurants and other sources). SNAP participants will be compared to income-eligible nonparticipants at income levels up to 200% of the federal poverty level.
2003-2014
Whole fruit
Time Frame: 2003-2014
Cup-equivalent servings of whole fruits consumed by SNAP participants compared to nonparticipants in 2003-2006 and 2011-2014 by source of food (including grocery stores, fast food restaurants, sit-down restaurants and other sources). SNAP participants will be compared to income-eligible nonparticipants at income levels up to 200% of the federal poverty level.
2003-2014
Whole grains
Time Frame: 2003-2014
Ounce-equivalents of whole grains consumed by SNAP participants compared to nonparticipants in 2003-2006 and 2011-2014 by source of food (including grocery stores, fast food restaurants, sit-down restaurants and other sources). SNAP participants will be compared to income-eligible nonparticipants at income levels up to 200% of the federal poverty level.
2003-2014

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of North Carolina, Chapel Hill

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Barry Popkin, PhD, University of North Carolina, Chapel Hill

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 1, 2003

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 31, 2014

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 31, 2014

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 1, 2017

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 7, 2017

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
December 13, 2017

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
December 13, 2017

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 7, 2017

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
December 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 12-2163
  • R01DK098072 (U.S. NIH Grant/Contract)
  • P2CHD050924 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings